SALVATI, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 723
EU - Europa 432
AS - Asia 200
AF - Africa 1
Totale 1.356
Nazione #
US - Stati Uniti d'America 722
IT - Italia 153
IE - Irlanda 105
SE - Svezia 86
HK - Hong Kong 83
RU - Federazione Russa 50
CN - Cina 39
JO - Giordania 35
SG - Singapore 28
CH - Svizzera 15
DE - Germania 6
FI - Finlandia 6
GB - Regno Unito 4
JP - Giappone 3
KR - Corea 3
NL - Olanda 3
ID - Indonesia 2
MM - Myanmar 2
UA - Ucraina 2
VN - Vietnam 2
CA - Canada 1
GR - Grecia 1
IN - India 1
RO - Romania 1
SC - Seychelles 1
TR - Turchia 1
TW - Taiwan 1
Totale 1.356
Città #
Dublin 105
Ashburn 89
Fairfield 87
Chandler 83
Hong Kong 57
Moscow 50
Woodbridge 42
Houston 36
Cambridge 35
Wilmington 31
Florence 27
Altamura 26
Lawrence 26
Seattle 22
Buffalo 19
Princeton 19
Singapore 17
Kent 15
Shanghai 15
Washington 15
Bern 14
New York 14
Medford 11
Boston 10
Oristano 9
San Diego 9
Beijing 8
Ann Arbor 7
Sant'elpidio A Mare 6
Siena 6
West Jordan 6
Norwalk 5
Boardman 4
Campi Bisenzio 4
Napoli 4
Rome 4
Bremen 3
Cecina 3
Fiesole 3
Helsinki 3
Hillsboro 3
Kin 3
Lappeenranta 3
Luni 3
Pisa 3
Redmond 3
Seoul 3
Avellino 2
Bari 2
Chengdu 2
Falls Church 2
Ho Chi Minh City 2
Laurel 2
Livorno 2
Redwood City 2
San Giovanni Valdarno 2
Scarperia e San Piero 2
Yangon 2
Abenberg 1
Catanzaro 1
Cedar Knolls 1
Chicago 1
Fontebuona 1
Frankfurt am Main 1
Hangzhou 1
Henderson 1
Hsinchu 1
Jacksonville 1
Leawood 1
London 1
Mahé 1
Milan 1
Modena 1
Monmouth Junction 1
Monteriggioni 1
Naples 1
Peristerion 1
Pune 1
San Mateo 1
Santa Clara 1
Sesto Fiorentino 1
Signa 1
Soci 1
Specchia 1
Tianjin 1
Torino 1
Toronto 1
Utrecht 1
Totale 1.022
Nome #
The burden of cutaneous adnexal carcinomas and the risk of associated squamous cell carcinoma: a population-based study 109
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study 97
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients 86
Clinical and dermoscopic features of lichenoid keratosis: A retrospective case study 84
Clinical and Dermoscopic Features of Vulvar Melanosis over the Last 20 Years 73
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab 68
Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab 60
A clinical, pathological and immunohistochemical series of 9 cases of primary cutaneous apocrine carcinomas of the head and neck 52
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 52
Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individuals 50
Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection 48
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19 48
Spectrum of Fibrotic Lung Diseases 47
A gendered magnifying glass on COVID-19 42
SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron 37
Melanoma brain metastases: review of histopathological features and immune-molecular aspects 35
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization 33
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes: implications for booster strategies 33
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion 30
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 29
From Emollients to Biologicals: Targeting Atopic Dermatitis 24
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications 24
“Adrenaline junkie”: a case report of repeated use of epinephrine 23
Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature 22
Clonally expanded PD-1-expressing T cells are enriched in synovial fluid of juvenile idiopathic arthritis patients 21
Thymic stromal lymphopoietin and alarmins as possible therapeutical targets for asthma 20
Fourth Dose of mRNA COVID-19 Vaccine Transiently Reactivates Spike-Specific Immunological Memory in People Living with HIV (PLWH) 20
Alarming inflammation: The TGFβ1–Nrp1 pathway upregulates the IL-33 axis in lung ILC2s 19
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 19
Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and Polymyositis 15
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 14
Optimization of the diagnosis and characterization of gibberellin-regulated protein sensitization: An Italian cohort study 14
Musculin does not modulate the disease course of Experimental Autoimmune Encephalomyelitis and DSS colitis 14
Disseminated nocardiosis and anti-GM-CSF antibodies 13
Bendamustine impairs humoral but not cellular immunity to SARS-CoV-2 vaccination in rituximab-treated B-cell lymphoma-affected patients 8
Effect of antimetabolite regimen on cellular and humoral immune response to SARS-COV-2 vaccination in solid organ transplant recipients 8
Pembrolizumab-associated anti-MDA5 dermatomyositis in a patient with lung cancer: a first case report 5
Presentation and progression of MPO-ANCA interstitial lung disease 5
Therapeutical Targets in Allergic Inflammation 5
Totale 1.406
Categoria #
all - tutte 8.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.041


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202072 4 4 0 4 8 12 8 8 8 4 8 4
2020/2021215 4 2 21 47 30 10 2 16 21 16 26 20
2021/2022171 7 15 7 5 11 17 4 12 11 7 29 46
2022/2023511 35 95 29 26 25 83 68 29 66 11 23 21
2023/2024399 7 26 48 21 27 63 14 72 8 55 37 21
2024/202538 38 0 0 0 0 0 0 0 0 0 0 0
Totale 1.406